Acadia Pharmaceuticals Shares Down 22.1% Since SmarTrend's Sell Call (ACAD)
June 19, 2017 at 15:00 PM EDT
SmarTrend identified a Downtrend for Acadia Pharmaceuticals (NASDAQ:ACAD) on March 21st, 2017 at $36.14. In approximately 3 months, Acadia Pharmaceuticals has returned 22.10% as of today's recent price of...